Contact UsCareers
Top bar

Patients & Caregivers

Targeted approach to treating rare cancers

A patient-first approach

Our work revolves around a simple premise: Put patients at the center of everything we do. For patients living with rare tumors and aggressive cancers, our therapies have an opportunity to make a difference in their lives. By targeting the underlying tumor growth in patients with Notch-pathway activation, we may be able to deliver targeted therapy treatment options to address the unmet needs of people living with rare tumors and aggressive cancers.

Diseases we target

Ayala is currently developing potential therapies to treat the following tumors and cancer types:




Are you interested in participating in our clinical trial?

Find out if you are a candidate.